- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 6, 2024 | 6.58M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 7.02M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 3.76M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$5.24M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$19.36M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $6.78M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $11.52M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $38.78M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $5.87M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $4.21M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$1.91M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$15.13M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $8.58M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $17.32M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $21.25M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $31.17M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $10.69M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $16.77M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $27.12M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $35.38M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.08 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$2.89 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.11 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$2.89 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $3.73M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $5.8M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $7.41M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $19.04M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$50K |
| Operating Income | Q1 2024 · Mar 31, 2023 | $11.79M |
| Capex | Q1 2024 · Mar 31, 2023 | $183K |